These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16118811)

  • 1. Single patient (n-of-1) trials with binary treatment preference.
    Schluter PJ; Ware RS
    Stat Med; 2005 Sep; 24(17):2625-36. PubMed ID: 16118811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale.
    Thompson SG; Warn DE; Turner RM
    Stat Med; 2004 Feb; 23(3):389-410. PubMed ID: 14748035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
    Zucker DR; Ruthazer R; Schmid CH; Feuer JM; Fischer PA; Kieval RI; Mogavero N; Rapoport RJ; Selker HP; Stotsky SA; Winston E; Goldenberg DL
    J Rheumatol; 2006 Oct; 33(10):2069-77. PubMed ID: 17014022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials.
    Huber AM; Tomlinson GA; Koren G; Feldman BM
    J Rheumatol; 2007 May; 34(5):1125-32. PubMed ID: 17444584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials.
    Turner RM; Omar RZ; Thompson SG
    Stat Med; 2006 May; 25(9):1443-56. PubMed ID: 16220510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting research in individual patients: lessons learnt from two series of N-of-1 trials.
    Wegman AC; van der Windt DA; Stalman WA; de Vries TP
    BMC Fam Pract; 2006 Sep; 7():54. PubMed ID: 16984636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian methods of analysis for cluster randomized trials with count outcome data.
    Clark AB; Bachmann MO
    Stat Med; 2010 Jan; 29(2):199-209. PubMed ID: 19856321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling risk when binary outcomes are subject to error.
    McInturff P; Johnson WO; Cowling D; Gardner IA
    Stat Med; 2004 Apr; 23(7):1095-109. PubMed ID: 15057880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian inference for randomized clinical trials with treatment failures.
    Shaffer ML; Chinchilli VM
    Stat Med; 2004 Apr; 23(8):1215-28. PubMed ID: 15083479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Bayesian adaptive randomization based on event times with covariates.
    Cheung YK; Inoue LY; Wathen JK; Thall PF
    Stat Med; 2006 Jan; 25(1):55-70. PubMed ID: 16025549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating a treatment effect in survival studies in which patients switch treatment.
    Branson M; Whitehead J
    Stat Med; 2002 Sep; 21(17):2449-63. PubMed ID: 12205692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint.
    Nixon RM; Duffy SW; Fender GR
    BMC Med Res Methodol; 2003 Sep; 3():17. PubMed ID: 14507420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: a tutorial.
    Zohar S; Teramukai S; Zhou Y
    Contemp Clin Trials; 2008 Jul; 29(4):608-16. PubMed ID: 18201945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
    Zucker DR; Schmid CH; McIntosh MW; D'Agostino RB; Selker HP; Lau J
    J Clin Epidemiol; 1997 Apr; 50(4):401-10. PubMed ID: 9179098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-parametric modelling for costs of health care technologies.
    Conigliani C; Tancredi A
    Stat Med; 2005 Oct; 24(20):3171-84. PubMed ID: 15568210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.